Your insurer said no.
You don't have to accept it.

Everything you need to appeal a GLP-1 medication denial.

Written by people who understand the system.

Designed for people who don't have time to figure it out alone.

Instant digital download.

Only 12%

of denied GLP-1 claims are ever appealed — the system depends on patients not knowing they can fight back. Our toolkit helps you do that.

1 in 2

internal appeals result in the insurer reversing their own denial. Our toolkit increases your chances of success.

40-60%

of denials that reach independent external review are overturned — and the insurer must comply.

Insurance companies count on you giving up.

Insurance claims for GLP-1 medications like Wegovy®, Ozempic®, Zepbound® and Mounjaro® are being denied at record rates.

But your doctor prescribed them because you need them.

Most patients never appeal — not because their case is weak, but because the process feels overwhelming.

And that's exactly what this toolkit fixes.

Get the Toolkit Now See What's Included

Frequently asked questions

No. The toolkit provides general information and document templates. It does not constitute legal advice, medical advice, or create any professional relationship.

Yes. The toolkit was designed for al GLP-1 drugs including Wegovy®, Ozempic®, Mounjaro®, and Zepbound®.

The toolkit covers all stages. If your first appeal is denied, use the Second Level Appeal Letter. It's not too late.

Appeal outcomes depend on your specific clinical situation and plan terms. This toolkit gives you the strongest possible case — it does not guarantee a result.

You will receive a ZIP file containing all 11 documents as PDF files and Microsoft Word files. Word files can also be opened in Google Docs or Apple Pages.